Publication | Open Access

Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents

Medicinal ChemistryPharmaceutical ChemistryNovel Anticancer AgentsMedicineDrug DiscoveryRational Drug DesignBiological EvaluationAniline DerivativesAnti-cancer AgentDrug DevelopmentPharmacologyDerivative (Chemistry)Biomolecular Engineering